Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary sequence data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watson, M. E.
Right arrow Articles by Smith, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watson, M. E., Jr
Right arrow Articles by Smith, A. L.
Agricola
Right arrow Articles by Watson, M. E.
Right arrow Articles by Smith, A. L.
Microbiology 150 (2004), 2947-2958; DOI  10.1099/mic.0.27230-0
© 2004 Society for General Microbiology

Hypermutable Haemophilus influenzae with mutations in mutS are found in cystic fibrosis sputum

Michael E. Watson, Jr1,2, Jane L. Burns3 and Arnold L. Smith1

1 Seattle Biomedical Research Institute, 307 Westlake Ave N, Suite 500, Seattle, WA 98109, USA
2 Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri-Columbia, Columbia, MO 65212, USA
3 Division of Infectious Diseases, Children's Hospital and Regional Medical Center, 4800 Sand Point Way, Seattle, WA 98105, USA

Correspondence
Arnold L. Smith
arnold.smith{at}sbri.org

Hypermutable bacterial pathogens exist at surprisingly high prevalence and benefit bacterial populations by promoting adaptation to selective environments, including resistance to antibiotics. Five hundred Haemophilus influenzae isolates were screened for an increased frequency of mutation to resistance to rifampicin, nalidixic acid and spectinomycin: of the 14 hypermutable isolates identified, 12 were isolated from cystic fibrosis (CF) sputum. Analysis by enterobacterial repetitive intergenic consensus (ERIC)-PCR and ribotyping identified eight distinct genetic fingerprints. The hypermutable phenotype of seven of the eight unique isolates was associated with polymorphisms in conserved sites of mutS. Four of the mutant mutS alleles were cloned and failed to complement the mutator phenotype of a mutS : : TSTE mutant of H. influenzae strain Rd KW20. Antibiotic susceptibility testing of the hypermutators identified one {beta}-lactamase-negative ampicillin-resistant (BLNAR) isolate with two isolates producing {beta}-lactamase. Six isolates from the same patient with CF, with the same genetic fingerprint, were clonal by multilocus sequence typing (MLST). In this clone, there was an evolution to higher MIC values for the antibiotics administered to the patient during the period in which the strains were isolated. Hypermutable H. influenzae with mutations in mutS are prevalent, particularly in the CF lung environment, and may be selected for and maintained by antibiotic pressure.


Abbreviations: BLNAR, {beta}-lactamase-negative ampicillin-resistant; CF, cystic fibrosis; ERIC, enterobacterial repetitive intergenic consensus; MLST, multilocus sequence typing; MMR, methyl-directed mismatch repair; PBP, penicillin-binding protein

The GenBank/EMBL/DDBJ accession numbers for the sequences reported in this paper are AY568590, AY568591, AY568592, AY568593, AY568594, AY568595, AY568596 and AY568597.




This article has been cited by other articles:


Home page
J. Bacteriol.Home page
A. M. Marcobal, D. A. Sela, Y. I. Wolf, K. S. Makarova, and D. A. Mills
Role of Hypermutability in the Evolution of the Genus Oenococcus
J. Bacteriol., January 15, 2008; 190(2): 564 - 570.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
T. Davidsen, H. K. Tuven, M. Bjoras, E. A. Rodland, and T. Tonjum
Genetic Interactions of DNA Repair Pathways in the Pathogen Neisseria meningitidis
J. Bacteriol., August 1, 2007; 189(15): 5728 - 5737.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
D. T. Kenna, C. J. Doherty, J. Foweraker, L. Macaskill, V. A. Barcus, and J. R. W. Govan
Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis
Microbiology, June 1, 2007; 153(6): 1852 - 1859.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
S. Montanari, A. Oliver, P. Salerno, A. Mena, G. Bertoni, B. Tummler, L. Cariani, M. Conese, G. Doring, and A. Bragonzi
Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosis
Microbiology, May 1, 2007; 153(5): 1445 - 1454.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. Perez-Vazquez, F. Roman, S. Garcia-Cobos, and J. Campos
Fluoroquinolone Resistance in Haemophilus influenzae Is Associated with Hypermutability
Antimicrob. Agents Chemother., April 1, 2007; 51(4): 1566 - 1569.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
L. M. C. Hall and S. K. Henderson-Begg
Hypermutable bacteria isolated from humans - a critical analysis.
Microbiology, September 1, 2006; 152(Pt 9): 2505 - 2514.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. D. Macia, N. Borrell, M. Segura, C. Gomez, J. L. Perez, and A. Oliver
Efficacy and Potential for Resistance Selection of Antipseudomonal Treatments in a Mouse Model of Lung Infection by Hypermutable Pseudomonas aeruginosa
Antimicrob. Agents Chemother., March 1, 2006; 50(3): 975 - 983.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
R. T. Cirz and F. E. Romesberg
Induction and Inhibition of Ciprofloxacin Resistance-Conferring Mutations in Hypermutator Bacteria
Antimicrob. Agents Chemother., January 1, 2006; 50(1): 220 - 225.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
E. Denamur, O. Tenaillon, C. Deschamps, D. Skurnik, E. Ronco, J. L. Gaillard, B. Picard, C. Branger, and I. Matic
Intermediate Mutation Frequencies Favor Evolution of Multidrug Resistance in Escherichia coli
Genetics, October 1, 2005; 171(2): 825 - 827.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2004 Society for General Microbiology.